Finance

Lists
FBRX:NASDAQ
Forte Biosciences Inc
$76.83
+0.29%
(+0.22) 1D
$76.83
0.00% (0.00)
After hours
Closed: Aug 6, 4:00:01 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for FBRX...
Open
$76.75
High
$76.83
Low
$76.72
Mkt. cap
1.57B
Avg. vol.
0.00
Volume
1.73M
52-wk high
$77.19
52-wk low
$9.91
EPS
-$4.58
Beta
2.62
Shares outstanding
20.49M
No. of employees
22
Open
$76.75
High
$76.83
Low
$76.72
Mkt. cap
1.57B
Avg. vol.
0.00
Volume
1.73M
52-wk high
$77.19
52-wk low
$9.91
EPS
-$4.58
Beta
2.62
Shares outstanding
20.49M
No. of employees
22
News stories
From sources across the web
About Forte Biosciences Inc
CEO-
Employees22
Founded2007
HeadquartersDallas, Texas, United States
SectorBiotechnology
Websitefortebiorx.com
Analyst ratings
Based on 6 analysts giving stock ratings to FBRX in the past 3 months
Buy
Buy
2
Hold
4
Sell
0
12-month forecast
Based on 6 Wall Street analysts offering 12 month price targets for FBRX in the last 3 months.
Highest
Current $76.83
$77.00 (+0.22%)
Average
$74.00 (-3.68%)
Lowest
$61.00 (-20.60%)
Analyst
Recommendation
Action
Price target
Projected
Date
Etzer Darout
Barclays
Hold
Downgraded
$77.00
+0.2%
07/27/2026
Kumaraguru Raja
Brookline Capital Markets
Hold
Downgraded
$77.00
+0.2%
07/27/2026
Gavin Clark-Gartner
Evercore ISI
Hold
Downgraded
$77.00
+0.2%
07/27/2026
Yaron Werber
TD Cowen
Hold
Downgraded
$77.00
+0.2%
07/27/2026
Yatin Suneja
Guggenheim
Buy
Reiterated
$75.00
-2.4%
07/09/2026
Daniil Gataulin
Chardan Capital
Buy
Reiterated
$61.00
-20.6%
05/11/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
8.62M
15.20M
21.74M
20.47M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
2.96M
3.18M
2.84M
1.97M
Operating expense
11.58M
18.38M
24.57M
22.44M
Total operating expenses
11.58M
18.38M
24.57M
22.44M
Operating income
-11.58M
-18.38M
-24.57M
-22.44M
Other non operating income
330.00K
701.00K
-1.65M
676.00K
EBT including unusual items
-11.25M
-17.68M
-23.75M
-21.76M
EBT excluding unusual items
-11.25M
-17.68M
-23.50M
-21.76M
Income tax expense
-
-
1.04M
373.00K
Effective tax rate
-
-
-4.37%
-1.71%
Other operating expenses
-
-
-
-
Net income
-11.25M
-17.68M
-24.79M
-22.14M
Net profit margin
-
-
-
-
Earnings per share
-0.96
-0.99
-1.45
-1.24
Interest and investment income
-
-
2.72M
-
Interest expense
-
-
-
-
Net interest expenses
-
-
2.72M
-
Depreciation and amortization charges
-
-
-
-
EBITDA
-11.56M
-18.37M
-24.55M
-22.42M
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

What's on your mind?
What's going on with the markets today?
Explore what’s possible
Create a portfolio
Create a task
Deep Search
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps